このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Sun Pharmaceutical Industries 過去の業績
過去 基準チェック /46
Sun Pharmaceutical Industriesは、平均年間27.4%の収益成長を遂げていますが、 Pharmaceuticals業界の収益は、年間 成長しています。収益は、平均年間15.2% 10.3%収益成長率で 成長しています。 Sun Pharmaceutical Industriesの自己資本利益率は15.6%であり、純利益率は21.1%です。
主要情報
27.4%
収益成長率
27.4%
EPS成長率
| Pharmaceuticals 業界の成長 | 17.5% |
| 収益成長率 | 10.3% |
| 株主資本利益率 | 15.6% |
| ネット・マージン | 21.1% |
| 前回の決算情報 | 30 Jun 2024 |
最近の業績更新
Recent updates
Pinning Down Sun Pharmaceutical Industries Limited's (NSE:SUNPHARMA) P/E Is Difficult Right Now
Aug 24
Sun Pharmaceutical Industries Limited Just Beat EPS By 10%: Here's What Analysts Think Will Happen Next
Aug 06This Is The Reason Why We Think Sun Pharmaceutical Industries Limited's (NSE:SUNPHARMA) CEO Might Be Underpaid
Jul 30Sun Pharmaceutical Industries (NSE:SUNPHARMA) Ticks All The Boxes When It Comes To Earnings Growth
Jun 30Sun Pharmaceutical Industries (NSE:SUNPHARMA) Has A Rock Solid Balance Sheet
Jun 12Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Annual Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 25Sun Pharmaceutical Industries Limited's (NSE:SUNPHARMA) Price Is Out Of Tune With Earnings
May 22Sun Pharmaceutical Industries (NSE:SUNPHARMA) Has A Rock Solid Balance Sheet
Mar 13Sun Pharmaceutical Industries' (NSE:SUNPHARMA) Upcoming Dividend Will Be Larger Than Last Year's
Feb 03Here's Why We Think Sun Pharmaceutical Industries (NSE:SUNPHARMA) Might Deserve Your Attention Today
Jan 05Getting In Cheap On Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Is Unlikely
Dec 18Is Now The Time To Put Sun Pharmaceutical Industries (NSE:SUNPHARMA) On Your Watchlist?
Oct 04Should You Be Adding Sun Pharmaceutical Industries (NSE:SUNPHARMA) To Your Watchlist Today?
Jul 03We Think Sun Pharmaceutical Industries (NSE:SUNPHARMA) Can Manage Its Debt With Ease
Jun 15Is Sun Pharmaceutical Industries (NSE:SUNPHARMA) A Risky Investment?
Mar 14Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Increasing Its Dividend To ₹7.50
Feb 03These 4 Measures Indicate That Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Using Debt Reasonably Well
Dec 09Does This Valuation Of Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Imply Investors Are Overpaying?
Oct 13These 4 Measures Indicate That Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Using Debt Safely
Sep 04Sun Pharmaceutical Industries' (NSE:SUNPHARMA) Upcoming Dividend Will Be Larger Than Last Year's
Aug 05Estimating The Intrinsic Value Of Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
Jul 12Does Sun Pharmaceutical Industries (NSE:SUNPHARMA) Have A Healthy Balance Sheet?
Jun 02収支内訳
収支内訳
Sun Pharmaceutical Industries の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Jun 24 | 492,088 | 103,895 | 95,551 | 0 |
| 31 Mar 24 | 484,969 | 95,764 | 95,025 | 0 |
| 31 Dec 23 | 474,446 | 89,063 | 93,681 | 0 |
| 30 Sep 23 | 463,049 | 85,485 | 90,419 | 0 |
| 30 Jun 23 | 450,648 | 84,352 | 86,821 | 0 |
| 31 Mar 23 | 438,857 | 84,736 | 83,549 | 0 |
| 31 Dec 22 | 424,018 | 42,119 | 80,549 | 0 |
| 30 Sep 22 | 410,239 | 41,047 | 78,688 | 0 |
| 30 Jun 22 | 396,975 | 38,894 | 76,169 | 0 |
| 31 Mar 22 | 386,545 | 32,727 | 73,544 | 0 |
| 31 Dec 21 | 377,307 | 64,441 | 71,354 | 0 |
| 30 Sep 21 | 367,044 | 62,378 | 70,049 | 0 |
| 30 Jun 21 | 356,316 | 60,036 | 68,619 | 0 |
| 31 Mar 21 | 334,981 | 29,038 | 69,042 | 0 |
| 31 Dec 20 | 331,601 | 24,095 | 68,729 | 0 |
| 30 Sep 20 | 324,782 | 14,706 | 67,016 | 0 |
| 30 Jun 20 | 320,484 | 7,219 | 65,810 | 0 |
| 31 Mar 20 | 328,375 | 37,649 | 63,986 | 0 |
| 31 Dec 19 | 318,165 | 40,010 | 64,149 | 0 |
| 30 Sep 19 | 314,018 | 43,293 | 63,608 | 0 |
| 30 Jun 19 | 302,161 | 29,956 | 62,101 | 0 |
| 31 Mar 19 | 290,659 | 26,654 | 61,027 | 0 |
| 31 Dec 18 | 288,052 | 34,379 | 58,539 | 0 |
| 30 Sep 18 | 277,182 | 24,380 | 57,316 | 0 |
| 30 Jun 18 | 275,048 | 35,690 | 54,702 | 0 |
| 31 Mar 18 | 264,155 | 20,957 | 54,814 | 0 |
| 31 Dec 17 | 263,811 | 20,763 | 54,007 | 0 |
| 30 Sep 17 | 276,530 | 31,827 | 52,432 | 0 |
| 30 Jun 17 | 295,310 | 45,057 | 49,929 | 0 |
| 31 Mar 17 | 313,081 | 69,644 | 50,285 | 0 |
| 31 Dec 16 | 319,185 | 73,270 | 49,986 | 0 |
| 30 Sep 16 | 311,431 | 74,000 | 49,212 | 0 |
| 30 Jun 16 | 297,512 | 61,937 | 48,012 | 0 |
| 31 Mar 16 | 281,086 | 45,457 | 49,076 | 0 |
| 31 Dec 15 | 266,281 | 38,915 | 95,369 | 0 |
| 30 Sep 15 | 264,670 | 28,702 | 95,000 | 0 |
| 30 Jun 15 | 276,422 | 38,150 | 45,608 | 0 |
| 31 Mar 15 | 273,920 | 45,394 | 46,483 | 0 |
| 31 Dec 14 | 170,765 | 59,141 | 45,586 | 0 |
| 30 Sep 14 | 170,835 | 60,202 | 45,036 | 0 |
| 30 Jun 14 | 165,250 | 58,100 | 44,680 | 0 |
| 31 Mar 14 | 160,804 | 31,415 | 44,040 | 0 |
| 31 Dec 13 | 150,933 | 26,104 | 35,071 | 0 |
| 30 Sep 13 | 136,587 | 19,606 | 33,778 | 0 |
質の高い収益: SUNPHARMAは 高品質の収益 を持っています。
利益率の向上: SUNPHARMAの現在の純利益率 (19.7%)は、昨年(19.3%)よりも高くなっています。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: SUNPHARMAの収益は過去 5 年間で年間26.3%増加しました。
成長の加速: SUNPHARMAの過去 1 年間の収益成長率 ( 23.2% ) は、5 年間の平均 ( 年間27.4%を下回っています。
収益対業界: SUNPHARMAの過去 1 年間の収益成長率 ( 23.2% ) はPharmaceuticals業界19.3%を上回りました。
株主資本利益率
高いROE: SUNPHARMAの 自己資本利益率 ( 15.6% ) は 低い とみなされます。